Companies such as Zydus Cadila, Bharat Biotech, Dr Reddys-Gamaleya
Institute, Serum Institute-AstraZeneca and Gennova are expected to
submit their safety and efficacy data for approval with the drug
regulator.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/india-may-have-500-million-covid-19-vaccine-doses-by-march/articleshow/79712947.cms
No comments:
Post a Comment